Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Molecular Neurobiology|November 25, 2011
Activity regulation of adenosine deaminases acting on RNA (ADARs)Cesare Orlandi, Alessandro Barbon, Sergio BarlatiGenes|January 25, 2025
ADAR Therapeutics as a New Tool for Personalized MedicineMatteo Bertoli, Luca La Via, Alessandro BarbonMolecular Neurobiology|February 21, 2018
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and DiseaseJessica Mingardi, Laura Musazzi, Giuseppina De Petro, et al.Molecular Neurobiology|October 22, 2016
The Good and the Bad of Glutamate Receptor RNA EditingAlice Filippini, Daniela Bonini, Luca La Via, et al.Neurobiology of Disease|January 19, 2013
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's diseaseChiara Fiorentini, Paola Savoia, Daria Savoldi, et al.Molecular Psychiatry|June 30, 2023
Stress, microRNAs, and stress-related psychiatric disorders: an overviewLaura Musazzi, Jessica Mingardi, Alessandro Ieraci, et al.Acta Neuropathologica Communications|May 12, 2025
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrilsAlice Filippini, Giulia Carini, Alessandro Barbon, et al.American Journal of Medical Genetics|March 29, 2002
Sequencing of the GRIK1 gene in patients with juvenile absence epilepsy does not reveal mutations affecting receptor structureClaudia Izzi, Alessandro Barbon, Rebekka Kretz, et al.Brain Research. Molecular Brain Research|October 16, 2003
Glutamate receptor RNA editing: a molecular analysis of GluR2, GluR5 and GluR6 in human brain tissues and in NT2 cells following in vitro neural differentiationAlessandro Barbon, Ivan Vallini, Luca La Via, et al.Pageof 7